"Serum Institute"
Latest news and video coverage curated from trusted media outlets
You Might Like
Serum Institute working on Omicron-specific vaccine, can be expected in next six months: Adar PoonawallaMHRA authorised the vaccine in the UK for adult booster doses "after it met safety, quality, and efficacy requirements," the agency stated.DNA - Published | |
Serum Institute’s Cervavac to prevent cervical cancer gets DGCI nodIndian Express - Published | |
Serum Institute of India to launch indigenously made vaccine to treat cervical cancerSerum Institute of India CEO Adar Poonawalla on Tuesday said the company plans to launch its indigenously-developed vaccine to treat cervical cancer in women later this year.IndiaTimes - Published | |
SII gets govt nod to export 32.4 lakh doses of Covovax vaccine to USThe government has allowed Serum Institute of India (SII) to supply 32.4 lakh doses of its Covid-19 jab Covovax under the brand name Nuvaxovid to the US, which will be the first vaccine to be exported..IndiaTimes - Published | |
Government panel recommends emergency approval of Serum Institute’s Covovax for 7-11 year age group"The Subject Expert Committee of Drugs Controller General Of India (DCGI) has recommended Serum Institute of India`s (SII) vaccine Covovax for children in the age group of 7-11 years," sources..Zee News - Published Also reported by •IndiaTimes | |
`Never been a better time to be vaccine manufacturer`: Serum Institute planning to set up its 1st plant in AfricaAsked about concerns over the rise of monkeypox cases, Serum Institute of India Chief Executive Adar Poonawalla said he believed the "disease was not so infectious", Reuters reported.Zee News - Published | |
Poonawalla woos Musk to invest in making Tesla cars in IndiaSerum Institute of India (SII) CEO Adar Poonawalla on Sunday wooed Elon Musk to invest in India to manufacture Tesla electric cars, saying it will be the best investment he would have ever made. Musk,..IndiaTimes - Published | |
Vaccine King Adar Poonawalla invites Elon Musk to make Tesla cars in India, says 'will be your best investment'Adar Poonawalla, CEO of Serum Institute of India, has invited Elon Musk to invest in India; this invitation comes amidst reports of Tesla CEO putting brakes on his India plans.Zee News - Published | |
India’s Covid-19 vaccine Covovax available for everyone above age of 12 years: Serum Institute CEO Adar Poonawalla"A lot of you have asked if Covovax is available for adults. The answer is yes, it is available for everyone above the age of 12," Poonawalla tweeted.Zee News - Published | |
Covid-19 vaccine Covovax now available for children in India: Adar PoonawallaSerum Institute of India (SII) CEO Adar Poonawalla on Tuesday said that the Covid-19 vaccine Covovax is now available in India for children. He also hailed PM Narendra Modi for his vision of providing..IndiaTimes - Published | |
Govt unlikely to procure SII’s Covovax for 12-17 age groupAs majority of youngsters has already taken the first dose of Covid vaccine, the government is unlikely to procure Serum Institute of India’s Covovax for use in adolescents of 12-17 years under the..IndiaTimes - Published | |
NTAGI panel recommends inclusion of Covovax in inoculation drive for 12-17 age groupSerum Institute of India (SII) Director for Government and Regulatory Affairs Prakash Kumar Singh had written to the Union Health Ministry recently, rDNA - Published | |
BREAKING: NTAGI approves SII`s Covid-19 vaccine Covovax for 12-17 age group, say sourcesThe National Technical Advisory Group on Immunization (NTAGI) on Friday approved Serum Institute of India's Covid-19 vaccine Covovax for the 12-17 age group, as per ANI.Zee News - Published | Covid-19: Serum Institute of India halts vaccine production over millions of unused dosesSerum Institute of India Ltd., the world’s largest vaccine manufacturer and a key supplier of Covid-19 inoculations to developing countries, has stopped making fresh batches of shots after its..IndiaTimes - Published |
Adar Poonawalla says Serum Institute has stopped vaccine production to avoid wasteIndian Express - Published | Indian Covid vaccines better than Pfizer, Moderna: Adar PoonawallaSerum Institute of India CEO Adar Poonawalla on Wednesday claimed that "Made in India" Covid vaccines have provided more protection against the coronavirus infection than mRNA vaccines like Pfizer and..IndiaTimes - Published |
Covid-19 fourth wave scare: `India is now better prepared`, says Adar PoonawallaComparing the situations and availabilities of medicines and technologies in year 2020 to 2022, Serum Institute of India CEO Adar Poonawalla talked about how India is better prepared for this time.Zee News - Published | Reduce time gap for Covid vaccine booster dose to six months: Serum Institute to govtVaccine major Serum Institute of India (SII) has appealed to the government to reduce the gap between the second and booster dose to six months from nine months at present to safeguard people against..IndiaTimes - Published |
Covid vaccines get big price cut! Covishield, Covaxin to be given at Rs 225 in private hospitalsVaccine majors Serum Institute of India (SII) and Bharat Biotech on Saturday said they have decided to cut prices of the precaution dose of their respective COVID-19 vaccines to Rs 225 per shot for..Zee News - Published | Covishield, Covaxin prices slashed ahead of booster drive expansionSerum Institute of India has reduced the price of its Covishield vaccine from Rs 600 to Rs 225 per dose for private hospitals, the vaccine maker announced on Saturday. Bharat Biotech also slashed the..IndiaTimes - Published |
Serum Institute of India prices Covishield booster dose at Rs 600SII CEO Adar Poonawalla also welcomed the government's move to allow precautionary doses of the vaccine to all aged above 18 years.DNA - Published | Serum Institute's Covishield precaution dose priced at Rs 600 per shotVaccine maker Serum Institute of India (SII) on Friday said the precaution dose of its Covishield vaccine against Covid-19 will be priced at Rs 600 per shot for eligible individuals.IndiaTimes - Published |
No more free of cost, Serum Institute finalises the price of Covishield Booster doseGovernment have decided to allow Coronavirus booster shots to all adults from Sunday at private vaccination centres. The move was welcomed by Serum Institute of India CEO Adar Poonawalla today. He..Zee News - Published | Fourth wave of Covid-19 to hit India? Here`s what Serum Institute`s CEO Adar Poonawalla has to saySpeaking to reporters on the sidelines of the ‘Alternate Fuel Conclave’, the SII CEO said the reason behind the low number of Covid-19 cases at the moment is that the country chose the right..Zee News - Published |
SII’s Covovax for those aged 12+ gets panel nodThe Covid-19 working group under the government’s vaccine advisory body has recommended use of the Serum Institute of India’s Covovax in the national vaccination programme for those aged 12 years..IndiaTimes - Published | Novovax Covid-19 vaccine gets emergency use nod for those aged between 12-18 years in IndiaAccording to an official statement released by Novovax, the vaccine, also known as NVX-CoV2373, is manufactured and marketed in India by the Serum Institute of India (SII) under the brand name Covovax..Zee News - Published |
Novavax says its Covid vaccine gets India authorisation for adolescentsNovavax Inc on Tuesday said that the Drugs Controller General of India (DCGI) has granted emergency use authorisation for its Covid-19 vaccine for adolescents aged 12 to 17 in the country. The..IndiaTimes - Published | Covid-19: Covovax gets DCGI’s EUA nod for 12-17-year-oldsIn a move that will further expand the basket of Covid vaccines approved for adolescents, the drug regulator has given emergency approval to Serum Institute of India’s Covovax for use in 12-17 year..IndiaTimes - Published |
BREAKING: SII`s Covid-19 vaccine ‘Covovax’ gets emergency use nod for children aged above 12 years"Novavax in global trials has demonstrated more than 90 per cent efficacy. Serum Institute of India`s brand Covovax has completed bridging studies in India and has been granted Emergency Use..Zee News - Published | DCGI's EUA nod to Covovax for 12-17 years age groupIndia's drug regulator has granted restricted emergency use authorisation to Serum Institute of India's COVID-19 vaccine Covovax for the 12-17 years age group subject to certain conditions, official..IndiaTimes - Published |
SEC recommends granting emergency use authorisation to Serum Institute of India's Covovax COVID-19 vaccinenewKerala.com - Published | Government panel recommends EUA for Covid vaccine Covovax for 12-17 age groupPrakash Kumar Singh, director-government and regulatory affairs at Serum Institute of India (SII), had submitted an application to the DCGI on February 21, seeking EUA for Covovax for the 12 to 17..IndiaTimes - Published |
Explained: How mRNA vaccine is differentIndia has approved nine COVID-19 vaccines up until now, of which three - Serum Institute of India's Covishield, Bharat Biotech's Covaxin and Russian vaccine Sputnik V - are being administered in India..IndiaTimes - Published | 230 kids aged 2-6 become youngest to get Covid jabs in Covovax trialA group of 230 children aged two to six have become the youngest in the country to get a Covid vaccine after they were given at least one dose during trials of the Covovax jab, manufacturer Serum..IndiaTimes - Published |
Serum Institute seeks EUA for its Covovax vaccine for 12-17 yrs age groupIndian Express - Published Also reported by •Zee News | Covid-19: 3 shots okayed last year still not part of vaccination driveThree vaccines against Covid-19 — Covovax, Corbevax and ZyCov-D — which received the Drug Controller General of India’s nod last year for emergency use in the country are yet to be used in the..IndiaTimes - Published |
DCGI approves for Bharat Biotech to conduct intranasal booster dose trialsThe DGCI also approved the market sale of Bharat Biotech's Covaxin and Serum Institute of India's CovishieldDNA - Published | Covid-hit world doubled vaccine delivery to 11 billion in 2021; SII produced 13% of shotsA total of 11 billion Covid-19 vaccine doses were produced and delivered to countries globally in 2021, which is twice the volume of the total global vaccine market in the pre-Covid year, 2019, for..IndiaTimes - Published |
Novavax, Serum Institute file for emergency use authorisation of Novavax' COVID-19 vaccine in South AfricanewKerala.com - Published | Serum Institute has applied for full market authorisation of Covishield: CEO Adar PoonawalaSerum Institute has applied to the Indian health ministry and Central Drugs Standard Control Organisation (CDSCO) for full market authorisation for its Covishield vaccine, company's CEO Adar Poonawalla..IndiaTimes - Published |
Corbevax, Covovax, Molnupiravir: All about India`s 3 new COVID19 vaccines, how they will be administeredSix COVID-19 vaccines - Serum Institute's Covishield, Bharat Biotech's Covaxin, Zydus Cadila's ZyCoV-D, Russia's Sputnik V and the US-made Moderna and Johnson and Johnson - had already received EUA..Zee News - Published | Bio E's Corbevax, SII's Covovax & antiviral drug Molnupiravir get EUA nodIn a significant boost for India’s fight against Covid-19, the Central Drugs Standard Control Organisation (CDSCO) has granted emergency use authorisation for two more Covid-19 vaccines – Corbevax..IndiaTimes - Published |
Covovax gets WHO's approval: What we know so farOn Friday, the World Health Organization (WHO) granted emergency use approval to Serum Institute's Covovax vaccine, making it the 9th COVID-19 vaccine to get WHO's approval.IndiaTimes - Published | Serum Institute CEO hails WHO's approval of Covovax for emergency useIndiaTimes - Published |
WHO approves Serum Institute`s COVID vaccine, CovovaxCovovax is the Serum Institute of India's version of the Novavax vaccine.Zee News - Published | WHO approves SII's Covovax for emergency useCovavax is the Indian version of the Novavax vaccine brought in India by the Serum Institute of India for children.DNA - Published |
Poonawalla family donates Rs 500 crore to Oxford UniversityThe owners of the Serum Institute of India, the Poonawalla family, have announced a £50 million (Rs 500 crore) donation to Oxford University to build a new research centre focused on vaccinology.IndiaTimes - Published | Working to develop COVID vaccine booster shot which is more effective against Omicron: Serum InstituteSII Chief Executive Officer Adar Poonawalla said COVID vaccines for children aged above 3 years will be launched in the next 6 months.Zee News - Published |
